ERBB2 and carcinoma: If the IHC result is score 2+, such patients are tested for HER2 amplification by ISH; most commonly fluorescence in situ hybridisation (FISH), to assess the average HER2 gene and chromosome enumeration probe 17 (CEP17) copy numbers (CNs) per carcinoma cell and the ratio of these [5].